黄素对莱迪格细胞功能的影响和潜在的治疗用途
Trinidad Raices1,2, María Luisa Varela3, Adriana María Belén Abiuso1
1Laboratory of Molecular Endocrinology and Signal Transduction, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina.
Endocrine oncology (Bristol, England)
|July 12, 2023
概括
库尔库明刺激类固醇生成,并抑制Leydig细胞瘤的生长在体外和体内. 这种天然化合物在不影响丸完整性的情况下,对莱迪格细胞瘤具有治疗潜力.
科学领域:
- 内分泌学 在内分泌学.
- 癌症生物学 癌症生物学
- 自然产品研究 自然产品研究
背景情况:
- 莱迪格细胞对于的产生至关重要,可以发展为莱迪格细胞瘤 (LCT).
- 慢性结核病会引起严重的健康问题,恶性形式对传统疗法具有抗性.
- 黄素对丸功能和LCTs的治疗潜力仍然在很大程度上未被探索.
研究的目的:
- 研究黄素对莱迪格细胞功能的影响,包括类固醇生成和增殖.
- 为了评估黄素在抑制莱迪格细胞瘤生长中的有效性.
- 评估黄素关于一般健康和丸完整性的安全概况.
主要方法:
- 使用MA-10莱迪格细胞进行体外研究,以评估类固醇生成和增殖.
- 在体内实验涉及瘤注射与黄素治疗的小鼠.
- 分析瘤体积,体重,生长曲线和一般健康参数.
主要成果:
- 黄素 (20-80μmol/L) 增强了急性类固醇发生和增加了莱迪格细胞中的STAR表达.
- 黄素 (40-80μmol/L) 通过诱导G2/M停止和亡,降低了莱迪格细胞的增殖.
- 黄素治疗显著抑制了小鼠的莱迪格细胞瘤生长,减少了瘤体积和体重.
结论:
- 黄素积极调节莱迪格细胞的类固醇生成,并在体外对莱迪格细胞表现出细胞静止作用.
- 在体内,黄素在抑制莱迪格细胞瘤生长方面表现出显著的有效性.
- 黄素是莱迪格细胞瘤的有希望的天然治疗剂,没有观察到对丸健康的不良影响.
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Target Cell Response to Hormones
3.1K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.1K
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
198
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
198
Testosterone: Functions and Regulation
768
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
768


